Vote Scores
Filings read through

Trevi Therapeutics, Inc.: how funds voted at the meeting of 3 Jun 2026

Ticker
TRVI
Meeting
Season
year to 30 June 2026
Filers reporting
275
Ballot items
5

275 filers on Form N-PX reported votes at the Trevi Therapeutics, Inc. meeting of 3 Jun 2026. The records fall into 5 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    1 nominee. 63.0% of the reported votes are for. 41 filers withheld from or voted against at least one nominee.

    167 vote records from 92 filers. 37 of the 92 filers that marked the item voted against management.

    • Positions of 31 fund families
    • For 15
    • Abstain or withhold 16
    • Against management 15
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    393 vote records from 274 filers. 23 of the 263 filers that marked the item voted against management. 11 filers gave no management mark.

    • Positions of 38 fund families
    • For 37
    • Against 1
    • Against management 1
  3. Item 3: Audit-related items (auditor ratification)

    167 vote records from 92 filers. 1 of the 92 filers that marked the item voted against management.

    • Positions of 31 fund families
    • For 31
  4. Item 4: CAPITAL STRUCTURE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    167 vote records from 92 filers. 4 of the 92 filers that marked the item voted against management.

    • Positions of 31 fund families
    • For 30
    • Against 1
    • Against management 1
  5. Item 5: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    173 vote records from 94 filers. 1 of the 94 filers that marked the item voted against management.

    • Positions of 31 fund families
    • For 31

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Trevi Therapeutics, Inc., meeting of 3 Jun 2026Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor
AllianceBernsteinForFor
AllspringForFor
BlackRock and iSharesForFor
BNY MellonForNo report
Brighthouse FundsForFor
Charles SchwabForFor
Columbia ThreadneedleForNo report
DimensionalForFor
DWSForFor
EquitableForFor
FidelityForFor
Franklin TempletonForNo report
Global XForFor
Goldman SachsForFor
Guggenheim and RydexForFor
Hartford FundsForFor
InvescoAgainst, against managementFor
J.P. MorganForNo report
John Hancock and ManulifeForFor
Lincoln FinancialForFor
MassMutualForFor
Morgan Stanley, Eaton Vance and CalvertForFor
NationwideForFor
Natixis and Loomis SaylesForNo report
Neuberger BermanForNo report
Northern Trust and FlexSharesForFor
Nuveen and TIAAForFor
Pacific Life fundsForFor
PGIM and PrudentialForNo report
PrincipalForFor
ProShares and ProFundsForFor
Russell InvestmentsForFor
SEIForFor
State Street and SPDRForFor
T. Rowe PriceForFor
VanguardForFor
Victory CapitalForFor
VoyaForFor

Questions

How many filers reported votes at the Trevi Therapeutics, Inc. meeting?
275 Form N-PX filers reported votes at the meeting of 3 Jun 2026. On say-on-pay, 23 of 263 filers that marked the item voted against management (8.7%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Trevi Therapeutics, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Trevi Therapeutics, Inc. with a meeting date within three days of 3 Jun 2026. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .